SEEG-Guided DBS for OCD
RecruitingNCT05623306Phase: NAStarted 2023-04-13
Summary
This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The stu
Eligibility
Sex
ALL
Min Age
22 Years
Max Age
75 Years
Locations
Stanford UniversityStanford, California, United States
University of PennsylvaniaPhiladelphia, Pennsylvania, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05623306